<DOC>
	<DOCNO>NCT01341028</DOCNO>
	<brief_summary>- Laparoscopic Roux-en-Y gastric bypass ( LRYGBP ) consider combination restriction-malabsorption procedure one common operative procedure implement . - Over last year increase evidence suggest beneficial effect bariatric operation might relate suppression appetite cause release anorectic gut hormone peptide-YY ( PYY ) glucagon-like peptide-1 ( GLP-1 ) L cell distal gut suppression orexigenic hormone ghrelin release stomach.Obese people blunt rise PYY GLP-1 meal , possibly result impaired satiety hence great food intake . - In present study investigator seek evaluate effect resection gastric fundus , main source ghrelin production , secretion ghrelin , PYY , GLP-1 insulin addition glucose level , appetite weight loss , morbidly obese patient undergo laparoscopic Roux-en-Y gastric bypass .</brief_summary>
	<brief_title>Gut Hormones After Roux-en-Y Gastric Bypass ( RYGBP ) Plus Gastric Fundus Resection</brief_title>
	<detailed_description>Twenty four patient include prospectively study . After randomization , 12 patient underwent LRYGBP 12 LRYGBP plus gastric fundus resection ( LRYGBP+FR ) . All human study perform accord principle Declaration Helsinki . The local Research Ethics Commitee University Hospital Patras approve study . Written inform consent obtain patient . All operation perform surgeon laparoscopically . The RYGBP procedure perform create small isolated less curve-based gastric pouch ( 20 ± 5 ml ) 150cm Roux limb . The gastroenteroanastomosis conduct 25 mm circular stapler . The dissection fundus stomach ( LRYGBP+FR ) group do use EndoGia No 60 . The subject study 3 , 6 12 month operation . All patient underwent oral glucose tolerance test ( OGTT ) 75 g glucose , preoperatively . In addition , venous blood collect overnight 12 hour fast 30 , 60 120 min administration 300 kcal mix meal.The meal consume ten minute consist 18 % protein , 55 % carbohydrate 27 % fat ( Resource energy drink , Nestle Nutrition , France ) . Plasma level PYY , GLP-1 , ghrelin insulin determine every time point study . All patient underwent complete clinical evaluation follow-up include nutritional , behavioral anthropometric parameter . Visual analogue scale ( VAS ) use measure hunger , nausea , fullness aversion food , 30 , 60 120 min consumption meal . Weight loss evaluation base postope¬rative body weight , body mass index ( BMI ) % excess weight loss ( EWL % ) . Insulin resistance approximate use homeostatic model assessment insulin resistance ( HOMA IR ) . The following formula use calculation : HOMA IR = ( fast glucose [ mmole ] /lt X fast insulin [ μU/ml ] ) /22.5 ) . The insulinogenic index , commonly use indicator pancreatic β-cell function , calculate ratio increment insulin concentration glucose concentration 30 minute meal ingestion ( Δ [ ins30 - ins0 ] / Δ [ Glu30 -Glu0 ] ) .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Body mass index high 40 kg/m2 pregnancy diabetes mellitus substance abuse chronic medical psychiatric illness previous gastrointestinal surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>weight loss</keyword>
	<keyword>appetite</keyword>
	<keyword>ghrelin</keyword>
	<keyword>PYY</keyword>
	<keyword>GLP-1</keyword>
	<keyword>insulin</keyword>
	<keyword>laparoscopic</keyword>
	<keyword>Roux-en-Y gastric bypass</keyword>
	<keyword>gastric fundus resection</keyword>
</DOC>